The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: Relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Smitka, Kvido ^a   Papezova, Hana ^b   Vondra, Karel ^a   Hill, Martin ^a   Hainer, Vojtech ^a   Nedvidkova, Jara ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; APPETITE STIMULANT; AUTOANTIBODY; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; DOPAMINE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; GHRELIN; GROWTH HORMONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; NEUTRALIZING ANTIBODY; NORADRENALIN; OBESTATIN; PEPTIDE YY; SEROTONIN; UNCLASSIFIED DRUG;

ACYLATION; ADIPOSE TIISSUE GUT BRAIN AXIS; ANOREXIA NERVOSA; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; BEHAVIOR CONTROL; BINDING AFFINITY; BULIMIA; CONNECTOME; DISEASE ASSOCIATION; DOWN REGULATION; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GENE; GENETIC VARIABILITY; GOAT GENE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUNGER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SATIETY; SENSORY NERVE; SIGNAL TRANSDUCTION; UPREGULATION; VAGUS NERVE;

EID: 84885353997     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/483145     Document Type: Review

References (268)

1. Hsu L. K. G., Epidemiology of the eating disorders. Psychiatric Clinics of North America 1996 19 4 681 700 2-s2.0-0029846997 10.1016/S0193-953X(05) 70375-0 (Pubitemid 26380368)
2. Vitiello B., Lederhendler I., Research on eating disorders: current status and future prospects. Biological Psychiatry 2000 47 9 777 786 2-s2.0-0034193295 10.1016/S0006-3223(99)00319-4 (Pubitemid 30254050)
3. Kaye W. H., Wagner A., Fudge J. L., Paulus M., Neurocircuity of eating disorders. Current Topics in Behavioral Neurosciences 2011 6 37 57
4. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders 2000 4th Washington, DC, USA American Psychiatric Association
5. Meguid M. M., Yang Z.-J., Gleason J. R., The gut-brain brain-gut axis in anorexia: toward an understanding of food intake regulation. Nutrition 1996 12 1 S57 S62 2-s2.0-0029933476
6. Smitka K., Papezova H., Vondra K., Hill M., Hainer V., Nedvidkova J., A higher response of plasma neuropeptide Y, growth hormone, leptin levels and extracellular glycerol levels in subcutaneous abdominal adipose tissue to Acipimox during exercise in patients with bulimia nervosa: single-blind, randomized, microdialysis study. Nutrition and Metabolism 2011 8, article 81 2-s2.0-81155127532 10.1186/1743-7075-8-81
7. Smitka K., Papezova H., Vondra K., Hill M., Hainer V., Nedvidkova J., Short-term exercise combined with Acipimox administration induces an increase in plasma ACTH levels and its subsequent fall in the recovery phase in bulimic women. Regulatory Peptides 2013 182 45 52
8. Konturek S. J., Konturek J. W., Pawlik T., Brzozowski T., Brain-gut axis and its role in the control of food intake. Journal of Physiology and Pharmacology 2004 55 1 137 154 2-s2.0-1842428652 (Pubitemid 38450982)
9. Romijn J. A., Corssmit E. P., Havekes L. M., Pijl H., Gut-brain axis. Current Opinion in Clinical Nutrition and Metabolic Care 2008 11 4 518 521 2-s2.0-54049084216 10.1097/MCO.0b013e328302c9b0
10. Roth C. L., Reinehr T., Roles of gastrointestinal and adipose tissue peptides in childhood obesity and changes after weight loss due to lifestyle intervention. Archives of Pediatrics and Adolescent Medicine 2010 164 2 131 138 2-s2.0-75849131328 10.1001/archpediatrics.2009.265
11. Sedlackova D., Kopeckova J., Papezova H., Vybíral S., Kvasnickova H., Hill M., Nedvidkova J., Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa before and after a high-carbohydrate breakfast. Physiological Research 2011 60 165 173
12. Smitka K., Papezova H., Kvasnickova H., Nedvidek J., Hainer V., Pacak K., Nedvidkova J., Godoy-Matos A., Wass J., Increased response of growth hormone and ghrelin to exercise and anti-lipolytic drug in bulimia nervosa patients. Proceedings of the 13th International Congress of Endocrinology November 2008 Rio de Janeiro, Brazil International Proceedings Division, Medimond Srl 445 449. http://www.medimond.com/proceedings/moreinfo/20081108.htm
13. Nedvidkova J., Smitka K., Papezova H., Vondra K., Hill M., Hainer V., Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women. Regulatory Peptides 2011 167 1 134 139 2-s2.0-79951674297 10.1016/j.regpep.2010.12.012
14. Sedlackova D., Kopeckova J., Papezova H., Hainer V., Kvasnickova H., Hill M., Nedvidkova J., Comparison of high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutrition & Metabolism 2012 9 52
15. Arosio M., Ronchi C. L., Gebbia C., Cappiello V., Beck-Peccoz P., Peracchi M., Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. Journal of Clinical Endocrinology and Metabolism 2003 88 2 701 704 2-s2.0-0037326118 10.1210/jc.2002-021161 (Pubitemid 36207811)
16. Stanley S., Wynne K., McGowan B., Bloom S., Hormonal regulation of food intake. Physiological Reviews 2005 85 4 1131 1158 2-s2.0-25444514533 10.1152/physrev.00015.2004 (Pubitemid 41363743)
17. Zhang J. V., Ren P.-G., Avsian-Kretchmer O., Luo C.-W., Rauch R., Klein C., Hsueh A. J. W., Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005 310 5750 996 999 2-s2.0-27744600963 10.1126/science.1117255 (Pubitemid 41611907)
18. Prince A. C., Brooks S. J., Stahl D., Treasure J., Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. American Journal of Clinical Nutrition 2009 89 3 755 765 2-s2.0-61449245518 10.3945/ajcn.2008.27056
19. Kaye W. H., Frank G. K., Bailer U. F., Henry S. E., Meltzer C. C., Price J. C., Mathis C. A., Wagner A., Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiology and Behavior 2005 85 1 73 81 2-s2.0-19744370315 10.1016/j.physbeh.2005.04.013 (Pubitemid 40744978)
20. Kaye W. H., Bailer U. F., Frank G. K., Wagner A., Henry S. E., Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiology and Behavior 2005 86 1-2 15 17 2-s2.0-24944435503 10.1016/j.physbeh.2005.06.019 (Pubitemid 41316603)
21. Kontis D., Theochari E., Dopamine in anorexia nervosa: a systematic review. Behavioural Pharmacology 2012 23 496 515
22. Haleem D. J., Serotonin neurotransmission in anorexia nervosa. Behavioural Pharmacology 2012 23 478 495
23. Kaye W. H., Wierenga C. E., Bailer U. F., Simmons A. N., Bischoff-Grethe A., Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends in Neurosciences 2013 36 110 120
24. Nonogaki K., Ohashi-Nozue K., Oka Y., A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochemical and Biophysical Research Communications 2006 341 3 703 707 2-s2.0-31744434071 10.1016/j.bbrc.2006.01.021 (Pubitemid 43177546)
25. Bradley R. L., Mansfield J. P. R., Maratos-Flier E., Neuropeptides, including neuropeptide y and melanocortins, mediate lipolysis in murine adipocytes. Obesity Research 2005 13 4 653 661 2-s2.0-32844463470
26. Schulpis K. H., Papassotiriou I., Vounatsou M., Karikas G. A., Tsakiris S., Chrousos G. P., Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. Journal of Clinical Endocrinology and Metabolism 2004 89 8 3983 3987 2-s2.0-4043126323 10.1210/jc.2004-0311 (Pubitemid 39071503)
27. Nedvídková J., Smitka K., Kopský V., Hainer V., Adiponectin, an adipocyte-derived protein. Physiological Research 2005 54 2 133 140 2-s2.0-18844409132 (Pubitemid 40686259)
28. Dostálová I., Smitka K., Papežová H., Kvasničková H., Nedvídková J., The role of adiponectin in increased insulin sensitivity of patients with anorexia nervosa. Vnitrni Lekarstvi 2006 52 10 887 890 2-s2.0-33749628164 (Pubitemid 44545132)
29. Dostálová I., Smitka K., Papežová H., Kvasničková H., Nedvídková J., Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiological Research 2007 56 5 587 594 2-s2.0-36949003187
30. Dostalova I., Bartak V., Papezova H., Nedvidkova J., The effect of short-term exercise on plasma leptin levels in patients with anorexia nervosa. Metabolism 2007 56 4 497 503 2-s2.0-33947281816 10.1016/j.metabol.2006.11.008 (Pubitemid 46427846)
31. Vargovic P., Ukropec J., Laukova M., Cleary S., Manz B., Pacak K., Kvetnansky R., Adipocytes as a new source of catecholamine production. FEBS Letters 2011 585 14 2279 2284 2-s2.0-79960356022 10.1016/j.febslet.2011.06.001
32. Kvetnansky R., Ukropec J., Laukova M., Manz B., Pacak K., Vargovic P., Stress stimulates production of catecholamines in rat adipocytes. Cellular and Molecular Neurobiology 2012 32 5 801 813 2-s2.0-84857718389 10.1007/s10571-012- 9822-6
33. Krykorkova I., Pacak K., Bartak V., Papezova H., Matejkova-Behanova M., Nedvidkova J., Increased basal and maprotiline-stimulated norepinephrine levels in abdominal fat in patients with anorexia nervosa. Diabetologie Metabolismus Endokrinologie Výživa 2001 supplement 3 28
34. Bartak V., Nedvidkova J., Vybiral S., Dostalova I., Papezova H., Simon M., Drbalova K., Vondra K., Pacak K., Adrenergic regulation of lipolysis in patients with anorexia nervosa during exercise. Physiological Research 2003 52 24P
35. Nedvidkova J., Dostalova I., Bartak V., Papezova H., Pacak K., Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study. Physiological Research 2004 53 409 413 (Pubitemid 39094829)
36. Bartak V., Vybiral S., Papezova H., Dostalova I., Pacak K., Nedvidkova J., Basal and exercise-induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosa. European Journal of Clinical Investigation 2004 34 5 371 377 2-s2.0-2942574344 10.1111/j.1365-2362.2004. 01344.x (Pubitemid 38748078)
37. Brambilla F., Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment. CNS Drugs 2001 15 2 119 136 2-s2.0-0035123699 (Pubitemid 32195106)
38. Takimoto Y., Inui A., Kumano H., Kuboki T., Orexigenic/anorexigenic signals in Bulimia nervosa. Current Molecular Medicine 2003 3 4 349 360 2-s2.0-0037767109 10.2174/1566524033479762 (Pubitemid 36621792)
39. Jimerson D. C., Wolfe B. E., Neuropeptides in eating disorders. CNS Spectrums 2004 9 7 516 522 2-s2.0-3342938172 (Pubitemid 38988547)
40. Harrold J. A., Hypothalamic control of energy balance. Current Drug Targets 2004 5 3 207 219 2-s2.0-1642263164 10.2174/1389450043490460 (Pubitemid 38372308)
41. Torsello A., Brambilla F., Tamiazzo L., Bulgarelli I., Rapetti D., Bresciani E., Locatelli V., Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa. Journal of Endocrinological Investigation 2007 30 11 962 976 2-s2.0-40149104419 (Pubitemid 351350833)
42. Nunn K., Frampton I., Lask B., Anorexia nervosa-a noradrenergic dysregulation hypothesis. Medical Hypotheses 2012 78 5 580 584 2-s2.0-84859270343 10.1016/j.mehy.2012.01.033
43. Corcos M., Atger F., Lévy-Soussan P., Avrameas S., Guilbert B., Cayol V., Jeammet P., Bulimia nervosa and autoimmunity. Psychiatry Research 1999 87 1 77 82 2-s2.0-0032863457 10.1016/S0165-1781(99)00048-7 (Pubitemid 29421701)
44. Fetissov S. O., Hamze Sinno M., Coquerel Q., Do Rego J. C., Coëffier M., Gilbert D., Hökfelt T., Déchelotte P., Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008 24 9 854 859 2-s2.0-49749124218 10.1016/j.nut.2008.06.021
45. Fetissov S. O., Harro J., Jaanisk M., Järv A., Podar I., Allik J., Nilsson I., Sakthivel P., Lefvert A. K., Hökfelt T., Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proceedings of the National Academy of Sciences of the United States of America 2005 102 41 14865 14870 2-s2.0-26844545833 10.1073/pnas.0507204102 (Pubitemid 41457147)
46. Fetissov S. O., In search of the missing link in the regulation of appetite and body weight. Nutrition 2009 25 3 252 254 2-s2.0-60149094195 10.1016/j.nut.2008.10.002
47. Fetissov S. O., Hamze Sinno M., Coëffier M., Bole-Feysot C., Ducrotté P., Hökfelt T., Déchelotte P., Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 2008 24 4 348 359 2-s2.0-39949083561 10.1016/j.nut.2007.12.006
48. Terashi M., Asakawa A., Harada T., Ushikai M., Coquerel Q., Sinno M. H., Déchelotte P., Inui A., Fetissov S. O., Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition 2011 27 4 407 413 2-s2.0-79952420839 10.1016/j.nut.2011.01.002
49. Radermecker R. P., Renard E., Scheen A. J., Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Diabetes/Metabolism Research and Reviews 2009 25 6 491 501 2-s2.0-70350614166 10.1002/dmrr.961
50. Franke B., Galloway T. S., Wilkin T. J., Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Diabetes/Metabolism Research and Reviews 2005 21 5 395 415 2-s2.0-24944512944 10.1002/dmrr.554 (Pubitemid 41320652)
51. Prioletta A., Muscogiuri G., Sorice G. P., Lassandro A. P., Mezza T., Policola C., Salomone E., Cipolla C., Della Casa S., Pontecorvi A., Giaccari A., In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance. Clinical Endocrinology 2011 75 2 202 206 2-s2.0-79960152354 10.1111/j.1365-2265.2011.04046.x
52. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K., Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 10 4753 4758 2-s2.0-17944379112 10.1210/jc.86.10.4753 (Pubitemid 33020516)
53. Zhu X., Cao Y., Voogd K., Steiner D. F., On the processing of proghrelin to ghrelin. Journal of Biological Chemistry 2006 281 38867 38870 (Pubitemid 46042013)
54. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 6762 656 660 2-s2.0-0033540056 10.1038/45230 (Pubitemid 129516334)
55. Yang J., Brown M. S., Liang G., Grishin N. V., Goldstein J. L., Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008 132 3 387 396 2-s2.0-38849090670 10.1016/j.cell.2008.01.017 (Pubitemid 351192001)
56. Müller T. D., Tschöp M. H., Jarick I., Ehrlich S., Scherag S., Herpertz-Dahlmann B., Zipfel S., Herzog W., de Zwaan M., Burghardt R., Fleischhaker C., Klampfl K., Wewetzer C., Herpertz S., Zeeck A., Tagay S., Burgmer M., Pfluger P. T., Scherag A., Hebebrand J., Hinney A., Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. Journal of Psychiatric Research 2011 45 5 706 711 2-s2.0-79955020763 10.1016/j.jpsychires.2010.10.001
57. Kirchner H., Gutierrez J. A., Solenberg P. J., Pfluger P. T., Czyzyk T. A., Willency T. A., Schürmann A., Joost H. G., Jandacek R. J., Hale J. E., Heiman M. L., Tschöp M. H., GOAT links dietary lipids with the endocrine control of energy balance. Nature Medicine 2009 15 741 745
58. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., Casanueva F. F., Deghenghi R., Camanni F., Ghigo E., Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. Journal of Endocrinological Investigation 2000 23 8 493 495 2-s2.0-0033805978
59. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M., The role of the gastric afferent vagal nerve in Ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002 123 4 1120 1128 2-s2.0-0036787457 10.1053/gast.2002.35954
60. Nonogaki K., Ghrelin and feedback systems. Vitamins and Hormones 2007 77 149 170 2-s2.0-35648977537 10.1016/S0083-6729(06)77007-8
61. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., Meguid M. M., Kasuga M., Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005 54 1 18 24 2-s2.0-10844287775 10.1136/gut.2004. 038737 (Pubitemid 40007213)
62. Cassoni P., Papotti M., Ghè C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., Muccioli G., Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. Journal of Clinical Endocrinology and Metabolism 2001 86 4 1738 1745 2-s2.0-17744396454 10.1210/jc.86.4.1738 (Pubitemid 32374931)
63. Banks W. A., Tschöp M., Robinson S. M., Heiman M. L., Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. Journal of Pharmacology and Experimental Therapeutics 2002 302 2 822 827 2-s2.0-0036073405 10.1124/jpet.102.034827 (Pubitemid 34787253)
64. Chen C.-Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.-C., Ueno N., Fujimiya M., Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005 129 1 8 25 2-s2.0-22344435662 10.1053/j.gastro.2005.04.015 (Pubitemid 41002038)
65. Inhoff T., Wiedenmann B., Klapp B. F., Mönnikes H., Kobelt P., Is desacyl ghrelin a modulator of food intake? Peptides 2009 30 5 991 994 2-s2.0-67349169801 10.1016/j.peptides.2009.01.019
66. Sedláčková D., Dostálová I., Hainer V., Beranová L., Kvasničková H., Hill M., Haluzík M., Nedvídková J., Simultaneous decrease of plasma obestatin and ghrelin levels after a high-carbohydrate breakfast in healthy women. Physiological Research 2008 57 1 S29 S37 2-s2.0-45849131257
67. Chen H. Y., Trumbauer M. E., Chen A. S., Weingarth D. T., Adams J. R., Frazier E. G., Shen Z., Marsh D. J., Feighner S. D., Guan X.-M., Ye Z., Nargund R. P., Smith R. G., Van Der Ploeg L. H. T., Howard A. D., Macneil D. J., Qian S., Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004 145 6 2607 2612 2-s2.0-2542475178 10.1210/en.2003-1596 (Pubitemid 38686204)
68. Hozumi H., Yamanouchi K., Nishihara M., Involvement of neuropeptide Y in hyperphagia in human growth hormone transgenic rats. Journal of Veterinary Medical Science 2006 68 9 959 965 2-s2.0-33749533253 10.1292/jvms.68.959 (Pubitemid 44526557)
69. Date Y., Shimbara T., Koda S., Toshinai K., Ida T., Murakami N., Miyazato M., Kokame K., Ishizuka Y., Ishida Y., Kageyama H., Shioda S., Kangawa K., Nakazato M., Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metabolism 2006 4 4 323 331 2-s2.0-33748946416 10.1016/j.cmet.2006.09.004 (Pubitemid 44430917)
70. Ogiso K., Asakawa A., Amitani H., Inui A., Ghrelin and anorexia nervosa: a psychosomatic perspective. Nutrition 2011 27 10 988 993 2-s2.0-80052733755 10.1016/j.nut.2011.05.005
71. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K., Ghrelin strongly stimulates growth hormone (GH) release in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 12 4908 4911 2-s2.0-0040184557 10.1210/jc.85.12.4908 (Pubitemid 32157685)
72. Vestergaard E. T., Dall R., Lange K. H. W., Kjaer M., Christiansen J. S., Jorgensen J. O. L., The ghrelin response to exercise before and after growth hormone administration. Journal of Clinical Endocrinology and Metabolism 2007 92 1 297 303 2-s2.0-33846056168 10.1210/jc.2006-1435 (Pubitemid 46067547)
73. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M. S., Tanaka M., Nozoe S.-I., Hosoda H., Kangawa K., Matsukura S., Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 2002 87 1 240 244 2-s2.0-18244391222 10.1210/jc.87.1.240 (Pubitemid 34084697)
74. Cummings D. E., Weigle D. S., Scott Frayo R., Breen P. A., Ma M. K., Patchen Dellinger E., Purnell J. Q., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 21 1623 1630 2-s2.0-0037162116 10.1056/NEJMoa012908 (Pubitemid 34755670)
75. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S., A role for ghrelin in the central regulation of feeding. Nature 2001 409 6817 194 198 2-s2.0-0035843183 10.1038/35051587 (Pubitemid 32144284)
76. Van Der Lely A. J., Ghrelin and new metabolic frontiers. Hormone Research 2009 71 1 129 133 2-s2.0-58549091080 10.1159/000178055
77. Kojima M., Kangawa K., Ghrelin: structure and function. Physiological Reviews 2005 85 2 495 522 2-s2.0-15544385058 10.1152/physrev.00012.2004 (Pubitemid 40404635)
78. Liu J., Lin H., Cheng P., Hu X., Lu H., Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes. Journal of Huazhong University of Science and Technology 2009 29 2 227 230 2-s2.0-65149096862 10.1007/s11596-009-0218-x
79. Rodríguez A., Gómez-Ambrosi J., Catalán V., Gil M. J., Becerril S., Sáinz N., Silva C., Salvador J., Colina I., Frühbeck G., Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. International Journal of Obesity 2009 33 541 552
80. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., Abribat T., Van Der Lely A. J., Ghigo E., Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 6 3062 3065 2-s2.0-2942666142 10.1210/jc.2003-031964 (Pubitemid 38766409)
81. Thompson N. M., Gill D. A. S., Davies R., Loveridge N., Houston P. A., Robinson I. C. A. F., Wells T., Ghrelin and des-octanoyl ghrelin promote adipogenesis directlyin vivo by a mechanism independent of GHS-R1a. Endocrinology 2004 145 1 234 242 2-s2.0-1042275336 10.1210/en.2003-0899 (Pubitemid 38202164)
82. Tebbe J. J., Tebbe C. G., Mronga S., Ritter M., Schäfer M. K. H., Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterology 2005 5, article 5 2-s2.0-25444433117 10.1186/1471-230X-5-5 (Pubitemid 41363853)
83. Kos K., Harte A. L., O'Hare P. J., Kumar S., McTernan P. G., Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT). Clinical Endocrinology 2009 70 3 383 389 2-s2.0-60449098658 10.1111/j.1365-2265.2008.03321.x
84. Misra M., Miller K. K., Stewart V., Hunter E., Kuo K., Herzog D. B., Klibanski A., Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. Journal of Clinical Endocrinology and Metabolism 2005 90 9 5082 5087 2-s2.0-24344477087 10.1210/jc.2005-0512 (Pubitemid 41262258)
85. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R. L., Heiman M. L., Lehnert P., Fichter M., Tschöp M., Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology 2001 145 5 669 673 2-s2.0-0035512816
86. Otto B., Tschöp M., Cuntz U., Letter to the Editor: similar fasting ghrelin levels in binge eating/purging anorexia nervosa and restrictive anorexia nervosa. Psychoneuroendocrinology 2004 29 5 692 693 2-s2.0-1642274645 10.1016/j.psyneuen.2004.01.001 (Pubitemid 38369170)
87. Troisi A., Di Lorenzo G., Lega I., Tesauro M., Bertoli A., Leo R., Iantorno M., Pecchioli C., Rizza S., Turriziani M., Lauro R., Siracusano A., Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 2005 81 4 259 266 2-s2.0-25844440015 10.1159/000087923 (Pubitemid 41397034)
88. Yin X., Li Y., Xu G., An W., Zhang W., Ghrelin fluctuation, what determines its production? Acta Biochimica et Biophysica Sinica 2009 41 3 188 197 2-s2.0-65249125294 10.1093/abbs/gmp001
89. Karczewska-Kupczewska M., Straczkowski M., Adamska A., Nikołajuk A., Otziomek E., Górska M., Kowalska I., Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. European Journal of Endocrinology 2010 162 2 235 239 2-s2.0-75149130596 10.1530/EJE-09-0832
90. Janas-Kozik M., Krupka-Matuszczyk I., Malinowska-Kolodziej I., Lewin-Kowalik J., Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regulatory Peptides 2007 140 1-2 43 46 2-s2.0-33847015683 10.1016/j.regpep.2006.11.005 (Pubitemid 46275058)
91. Nedvidkova J., Krykorkova I., Bartak V., Papezova H., Gold P. W., Alesci S., Pacak K., Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2003 88 4 1678 1682 2-s2.0-0038439260 10.1210/jc.2002-021669 (Pubitemid 36623387)
92. Hotta M., Ohwada R., Katakami H., Shibasaki T., Hizuka N., Takano K., Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5707 5712 2-s2.0-8744246376 10.1210/jc.2004-0353 (Pubitemid 39518462)
93. Germain N., Galusca B., Grouselle D., Frere D., Billard S., Epelbaum J., Estour B., Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2010 95 6 3057 3062 2-s2.0-77954520777 10.1210/jc.2009-2196
94. Scacchi M., Pincelli A. I., Cavagnini F., Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Frontiers in Neuroendocrinology 2003 24 3 200 224 2-s2.0-0142227703 10.1016/S0091-3022(03)00014-1 (Pubitemid 37329472)
95. Støving R. K., Andersen M., Flyvbjerg A., Frystyk J., Hangaard J., Vinten J., Koldkjær O. G., Hagen C., Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. Clinical Endocrinology 2002 56 3 391 396 2-s2.0-0036229754 10.1046/j.1365-2265.2002.01485.x (Pubitemid 34310018)
96. Gianotti L., Fassino S., Daga G. A., Lanfranco F., De Bacco C., Ramunni J., Arvat E., Maccario M., Ghigo E., Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to ghrh in anorexia nervosa. Clinical Endocrinology 2000 52 6 713 720 2-s2.0-0034049752 10.1046/j.1365-2265.2000.00990.x (Pubitemid 30409263)
97. Broglio F., Gianotti L., Destefanis S., Fassino S., Abbate Daga G., Mondelli V., Lanfranco F., Gottero C., Gauna C., Hofland L., Van Der Lely A. J., Ghigo E., The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clinical Endocrinology 2004 60 5 592 599 2-s2.0-2442684031 10.1111/j.1365-2265.2004. 02011.x (Pubitemid 38669849)
98. Misra M., Klibanski A., The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology 2011 93 2 65 73 2-s2.0-79952572943 10.1159/000323771
99. Fazeli P. K., Lawson E. A., Prabhakaran R., Miller K. K., Donoho D. A., Clemmons D. R., Herzog D. B., Misra M., Klibanski A., Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2010 95 11 4889 4897 2-s2.0-78049521759 10.1210/jc.2010-0493
100. Hasan T. F., Hasan H., Anorexia nervosa: a unified neurological perspective. International Journal of Medical Sciences 2011 8 8 679 703 2-s2.0-80555145067
101. Fazeli P. K., Misra M., Goldstein M., Miller K. K., Klibanski A., Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2010 95 1 369 374 2-s2.0-75149195216 10.1210/jc.2009-1730
102. Monteleone P., Carratù R., Cartenì M., Generoso M., Lamberti M., De Magistris L., Brambilla F., Colurcio B., Secondulfo M., Maj M., Intestinal permeability is decreased in anorexia nervosa. Molecular Psychiatry 2004 9 1 76 80 2-s2.0-0842286643 10.1038/sj.mp.4001374 (Pubitemid 38175084)
103. Naisberg Y., Modai I., Weizman A., Metabolic bioenergy homeostatic disruption: a cause of anorexia nervosa. Medical Hypotheses 2001 56 4 454 461 2-s2.0-0035040659 10.1054/mehy.2000.1199 (Pubitemid 32397878)
104. Hornig M., Lipkin W. I., Immune-mediated animal models of Tourette syndrome. Neuroscience & Biobehavioral Reviews 2013 37 1120 1138
105. Germain N., Galusca B., Grouselle D., Frere D., Tolle V., Zizzari P., Lang F., Epelbaum J., Estour B., Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology 2009 34 3 413 419 2-s2.0-59249099100 10.1016/j.psyneuen.2008.10.001
106. Nakai Y., Hosoda H., Nin K., Ooya C., Hayashi H., Akamizu T., Kangawa K., Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. European Journal of Endocrinology 2003 149 1 R1 R3 2-s2.0-0038825574 (Pubitemid 36874207)
107. Harada T., Nakahara T., Yasuhara D., Kojima S., Sagiyama K.-I., Amitani H., Laviano A., Naruo T., Inui A., Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biological Psychiatry 2008 63 2 245 247 2-s2.0-37349020266 10.1016/j.biopsych.2007.04.005 (Pubitemid 350299324)
108. Tanaka M., Naruo T., Muranaga T., Yasuhara D., Shiiya T., Nakazato M., Matsukura S., Nozoe S.-I., Increased fasting plasma ghrelin levels in patients with bulimia nervosa. European Journal of Endocrinology 2002 146 6 R1 R3 2-s2.0-0036299655 (Pubitemid 34705084)
109. Tanaka M., Naruo T., Nagai N., Kuroki N., Shiiya T., Nakazato M., Matsukura S., Nozoe S.-I., Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. Journal of Psychiatric Research 2003 37 1 17 22 2-s2.0-0037212072 10.1016/S0022-3956(02)00067-5 (Pubitemid 35449767)
110. Monteleone P., Martiadis V., Rigamonti A. E., Fabrazzo M., Giordani C., Muller E. E., Maj M., Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biological Psychiatry 2005 57 8 926 931 2-s2.0-16844369848 10.1016/j.biopsych.2005.01.004 (Pubitemid 40488362)
111. Kojima S., Nakahara T., Nagai N., Muranaga T., Tanaka M., Yasuhara D., Masuda A., Date Y., Ueno H., Nakazato M., Naruo T., Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clinical Endocrinology 2005 62 1 74 78 2-s2.0-19944431198 10.1111/j.1365-2265.2004.02176.x (Pubitemid 40175286)
112. Monteleone P., Martiadis V., Fabrazzo M., Serritella C., Maj M., Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychological Medicine 2003 33 8 1387 1394 2-s2.0-0345570518 10.1017/S0033291703008316 (Pubitemid 37483461)
113. Fassino S., Abbate Daga G., Mondelli V., Pierò A., Broglio F., Picu A., Giordano R., Baldi M., Arvat E., Ghigo E., Gianotti L., Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa. Psychoneuroendocrinology 2005 30 6 534 540 2-s2.0-20144387760 10.1016/j.psyneuen.2004.12.008 (Pubitemid 40461787)
114. Agnew A. J., Robinson E., McVicar C. M., Harvey A. P., Ali I. H. A., Lindsay J. E., McDonald D. M., Green B. D., Grieve D. J., The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling. British Journal of Pharmacology 2012 166 1 327 338 2-s2.0-84859722696 10.1111/j.1476-5381.2011.01761.x
115. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vázquez M. J., Wiedmer P., Castañeda T. R., DiMarchi R., Tschöp M., Schurmann A., Joost H.-G., Williams L. M., Langhans W., Diéguez C., Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007 148 1 21 26 2-s2.0-33845911774 10.1210/en.2006-0915 (Pubitemid 46021434)
116. Zamrazilová H., Hainer V., Sedláčková D., Papežová H., Kunešová M., Bellisle F., Hill M., Nedvídková J., Plasma obestatin levels in normal weight, obese and anorectic women. Physiological Research 2008 57 1 S49 S55 2-s2.0-45849110632
117. Haider D. G., Schindler K., Prager G., Bohdjalian A., Luger A., Wolzt M., Ludvik B., Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 3 1168 1171 2-s2.0-33947544987 10.1210/jc.2006-1839 (Pubitemid 46465698)
118. Gourcerol G., St-Pierre D. H., Taché Y., Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regulatory Peptides 2007 141 1-3 1 7 2-s2.0-33846926049 10.1016/j.regpep.2006. 12.023 (Pubitemid 46505037)
119. Van Dijck A., Van Dam D., Vergote V., De Spiegeleer B., Luyten W., Schoofs L., De Deyn P. P., Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. Regulatory Peptides 2009 156 1-3 77 82 2-s2.0-67649103527 10.1016/j.regpep.2009.04.014
120. Qader S. S., Håkanson R., Rehfeld J. F., Lundquist I., Salehi A., Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regulatory Peptides 2008 146 1-3 230 237 2-s2.0-38149098503 10.1016/j.regpep.2007.09.017
121. Samson W. K., White M. M., Price C., Ferguson A. V., Obestatin acts in brain to inhibit thirst. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 2007 292 1 R637 R643 2-s2.0-33846173353 10.1152/ajpregu.00395.2006 (Pubitemid 46089880)
122. Camiña J. P., Campos J. F., Caminos J. E., Dieguez C., Casanueva F. F., Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. Journal of Cellular Physiology 2007 211 1 1 9 2-s2.0-33847642830 10.1002/jcp.20925 (Pubitemid 46363890)
123. Kapica M., Zabielska M., Puzio I., Jankowska A., Kato I., Kuwahara A., Zabielski R., Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats-preliminary results. Journal of Physiology and Pharmacology 2007 58 3 123 130 2-s2.0-34948884102 (Pubitemid 47523109)
124. Ren A.-J., Guo Z.-F., Wang Y.-K., Wang L.-G., Wang W.-Z., Lin L., Zheng X., Yuan W.-J., Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochemical and Biophysical Research Communications 2008 369 3 969 972 2-s2.0-41149098483 10.1016/j.bbrc.2008.02.146
125. Pan W., Tu H., Kastin A. J., Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006 27 4 911 916 2-s2.0-33645420927 10.1016/j.peptides.2005.12.014
126. Vergote V., Van Dorpe S., Peremans K., Burvenich C., De Spiegeleer B., In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides 2008 29 10 1740 1748 2-s2.0-52049107373 10.1016/j.peptides. 2008.05.018
127. Egido E. M., Hernández R., Marco J., Silvestre R. A., Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regulatory Peptides 2009 152 1-3 61 66 2-s2.0-57249115880 10.1016/j.regpep.2008.08.003
128. Lauwers E., Landuyt B., Arckens L., Schoofs L., Luyten W., Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochemical and Biophysical Research Communications 2006 351 1 21 25 2-s2.0-33750980992 10.1016/j.bbrc.2006.09.141 (Pubitemid 44740415)
129. Zhang J. V., Jahr H., Luo C.-W., Klein C., Van Kolen K., Ver Donck L., De A., Baart E., Li J., Moechars D., Hsueh A. J. W., Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Molecular Endocrinology 2008 22 6 1464 1475 2-s2.0-44649103391 10.1210/me.2007-0569 (Pubitemid 351787005)
130. Egerod K. L., Holst B., Petersen P. S., Hansen J. B., Mulder J., Hökfelt T., Schwartz T. W., GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue. Molecular Endocrinology 2007 21 7 1685 1698 2-s2.0-34347254667 10.1210/me.2007-0055 (Pubitemid 47001091)
131. Catalán V., Gómez-Ambrosi J., Rotellar F., Silva C., Gil M. J., Rodríguez A., Cienfuegos J. A., Salvador J., Frühbeck G., The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clinical Endocrinology 2007 66 4 598 601 2-s2.0-33947220471 10.1111/j.1365-2265.2007. 02777.x (Pubitemid 46434943)
132. Dong X.-Y., He J.-M., Tang S.-Q., Li H.-Y., Jiang Q.-Y., Zou X.-T., Is GPR39 the natural receptor of obestatin? Peptides 2009 30 2 431 438 2-s2.0-58149522922 10.1016/j.peptides.2008.09.022
133. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., Nano R., Annunziata M., Campiglia P., Arnoletti E., Ghé C., Volante M., Papotti M., Muccioli G., Ghigo E., Obestatin promotes survival of pancreatic β -cells and human islets and induces expression of genes involved in the regulation of β -cell mass and function. Diabetes 2008 57 4 967 979 2-s2.0-42449124783 10.2337/db07-1104
134. Fujimiya M., Ataka K., Asakawa A., Chen C.-Y., Kato I., Inui A., Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides. Digestion 2012 85 2 90 94 2-s2.0-84856153396 10.1159/000334654
135. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M., Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2008 93 11 4418 4421 2-s2.0-57349151755 10.1210/jc.2008-1138 (Pubitemid 352789541)
136. Nakahara T., Harada T., Yasuhara D., Shimada N., Amitani H., Sakoguchi T., Kamiji M. M., Asakawa A., Inui A., Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biological Psychiatry 2008 64 3 252 255 2-s2.0-46449120007 10.1016/j.biopsych.2007.08.005 (Pubitemid 351927261)
137. Uehara M., Yasuhara D., Nakahara T., Harada T., Koyama K.-I., Ushikai M., Asakawa A., Inui A., Increase in energy intake leads to a decrease in obestatin in restricting-type of anorexia nervosa. Experimental and Clinical Endocrinology and Diabetes 2011 119 9 536 539 2-s2.0-80054752520 10.1055/s-0031-1279703
138. Neary N. M., Small C. J., Bloom S. R., Gut and mind. Gut 2003 52 7 918 921 2-s2.0-0038121858 10.1136/gut.52.7.918 (Pubitemid 36765278)
139. Sahu A., Kalra S. P., Neuropeptidergic regulation of feeding behavior: neuropeptide Y. Trends in Endocrinology and Metabolism 1993 4 7 217 224 2-s2.0-0027514809 10.1016/1043-2760(93)90125-X (Pubitemid 23293309)
140. Wynne K., Stanley S., McGowan B., Bloom S. R., Appetite control. Journal of Endocrinology 2005 184 2 291 318 2-s2.0-14844334627 10.1677/joe.1.05866 (Pubitemid 40347231)
141. Turtzo L. C., Lane M. D., NPY and neuron-adipocyte interactions in the regulation of metabolism. EXS 2006 95 133 141 2-s2.0-33644836239
142. Turtzo L. C., Marx R., Daniel Lane M., Cross-talk between sympathetic neurons and adipocytes in coculture. Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12385 12390 2-s2.0-0035940407 10.1073/pnas.231478898 (Pubitemid 33019955)
143. Nogueiras R., Williams L. M., Dieguez C., Ghrelin: new molecular pathways modulating appetite and adiposity. Obesity Facts 2010 3 5 285 292 2-s2.0-78049416218 10.1159/000321265
144. Coiro V., Volpi R., Cataldo S., Araldi A., Stella A., Saccani-Jotti G., Maffei M. L., Volta E., Chiodera P., Somatostatin reduces neuropeptide Y rise induced by physical exercise. Hormone and Metabolic Research 2011 43 5 361 363 2-s2.0-79955715080 10.1055/s-0031-1273681
145. Coiro V., Casti A., Volta E., Melani A., Rubino P., Saccani-Jotti G., Volpi R., Chiodera P., Effect of physical training on reduction of circulating neuropeptide Y levels in elderly humans. Journal of Endocrinological Investigation 2010 33 2 132 133 2-s2.0-77951788436 10.3275/6475
146. Antonijevic I. A., Murck H., Bohlhalter S., Frieboes R.-M., Holsboer F., Steiger A., Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 2000 39 8 1474 1481 2-s2.0-0034101606 10.1016/S0028-3908(00)00057-5 (Pubitemid 30249209)
147. Watanobe H., Tamura T., Stimulation by neuropeptide Y of growth hormone secretion in prolactinoma in vivo. Neuropeptides 1996 30 5 429 432 2-s2.0-0029973597 10.1016/S0143-4179(96)90005-0 (Pubitemid 26358854)
148. Watanobe H., Tamura T., Stimulatory and inhibitory effects of neuropeptide Y on growth hormone secretion in acromegaly in vivo. Neuropeptides 1997 31 1 29 34 2-s2.0-0031054419 10.1016/S0143-4179(97)90016-0 (Pubitemid 27112611)
149. Pihlajamäki J., Karhapää P., Vauhkonen I., Kekäläinen P., Kareinen A., Viitanen L., Pesonen U., Kallio J., Uusitupa M., Laakso M., The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism. Metabolism 2003 52 5 643 646 2-s2.0-0038748301 10.1053/meta.2003.50098 (Pubitemid 36896294)
150. Billington C. J., Briggs J. E., Grace M., Levine A. S., Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 1991 260 2 R321 R327 2-s2.0-0026022088
151. Kos K., Harte A. L., James S., Snead D. R., O'Hare J. P., McTernan P. G., Kumar S., Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. American Journal of Physiology. Endocrinology and Metabolism 2007 293 5 E1335 E1340 2-s2.0-36148983020 10.1152/ajpendo.00333.2007 (Pubitemid 350106602)
152. Yang K., Guan H., Arany E., Hill D. J., Cao X., Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB Journal 2008 22 7 2452 2464 2-s2.0-46749151329 10.1096/fj.07-100735 (Pubitemid 351948663)
153. Kos K., Baker A. R., Jernas M., Harte A. L., Clapham J. C., O'Hare J. P., Carlsson L., Kumar S., Mcternan P. G., DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes, Obesity and Metabolism 2009 11 4 285 292 2-s2.0-61549105354 10.1111/j.1463-1326.2008.00909.x
154. Kuo L. E., Czarnecka M., Kitlinska J. B., Tilan J. U., Kvetňanský R., Zukowska Z., Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Annals of the New York Academy of Sciences 2008 1148 232 237 2-s2.0-57649217286 10.1196/annals.1410.035
155. Eaton K., Sallee F. R., Sah R., Relevance of neuropeptide Y (NPY) in psychiatry. Current Topics in Medicinal Chemistry 2007 7 17 1645 1659 2-s2.0-36248946217 10.2174/156802607782341037 (Pubitemid 350131002)
156. Gruninger T. R., LeBoeuf B., Liu Y., Garcia L. R., Molecular signaling involved in regulating feeding and other motivated behaviors. Molecular Neurobiology 2007 35 1 1 19 2-s2.0-34347355525 10.1007/s12035-007-0008-z (Pubitemid 47010925)
157. Hökfelt T., Stanic D., Sanford S. D., Gatlin J. C., Nilsson I., Paratcha G., Ledda F., Fetissov S., Lindfors C., Herzog H., Johansen J. E., Ubink R., Pfenninger K. H., NPY and its involvement in axon guidance, neurogenesis, and feeding. Nutrition 2008 24 9 860 868 2-s2.0-49749112375 10.1016/j.nut.2008.06.010
158. Hargrave S. L., Kinzig K. P., Repeated gastric distension alters food intake and neuroendocrine profiles in rats. Physiology and Behavior 2012 105 4 975 981 2-s2.0-82655186616 10.1016/j.physbeh.2011.11.006
159. Baranowska B., Wasilewska-Dziubińska E., Radzikowska M., Płonowski A., Roguski K., Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism 1997 46 12 1384 1389 2-s2.0-0031439025 10.1016/S0026-0495(97)90136-0 (Pubitemid 28053201)
160. Nedvídková J., Papezová H., Haluzík M., Schreiber V., Interaction between serum leptin levels and hypothalamo- hypophyseal-thyroid axis in patients with anorexia nervosa. Endocrine Research 2000 26 2 219 230 2-s2.0-0343628688 (Pubitemid 30460841)
161. Baranowska B., Wolinska-Witort E., Wasilewska-Dziubinska E., Roguski K., Chmielowska M., Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuroendocrinology Letters 2001 22 5 356 358 2-s2.0-0034754370 (Pubitemid 33036845)
162. Oświecimska J., Ziora K., Geisler G., Broll-Waśka K., Prospective evaluation of leptin and neuropeptide Y (NPY) serum levels in girls with anorexia nervosa. Neuroendocrinology Letters 2005 26 4 301 304 2-s2.0-27244456936 (Pubitemid 41518765)
163. Sederholm F., Ammar A. A., Södersten P., Intake inhibition by NPY: role of appetitive ingestive behavior and aversion. Physiology and Behavior 2002 75 4 567 575 2-s2.0-0036534644 10.1016/S0031-9384(02)00648-0 (Pubitemid 34327964)
164. Ammar A. A., Nergårdh R., Fredholm B. B., Brodin U., Södersten P., Intake inhibition by NPY and CCK-8: a challenge of the notion of NPY as an "Orexigen" Behavioural Brain Research 2005 161 1 82 87 2-s2.0-19344363690 10.1016/j.bbr.2005.01.014 (Pubitemid 40719773)
165. Nergårdh R., Ammar A., Brodin U., Bergström J., Scheurink A., Södersten P., Neuropeptide Y facilitates activity-based-anorexia. Psychoneuroendocrinology 2007 32 5 493 502 2-s2.0-34249055840 10.1016/j.psyneuen.2007.03.002 (Pubitemid 46778948)
166. Pedersen-Bjergaard U., Høst U., Kelbæk H., Schifter S., Rehfeld J. F., Faber J., Christensen N. J., Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scandinavian Journal of Clinical and Laboratory Investigation 1996 56 6 497 503 2-s2.0-0029826237 (Pubitemid 26342634)
167. 3-36 in the mouse. Journal of Pharmacology and Experimental Therapeutics 2003 306 3 948 953 2-s2.0-0042433334 10.1124/jpet.103.051821 (Pubitemid 37025300)
168. 3-36 physiologically inhibits food intake. Nature 2002 418 6898 650 654 2-s2.0-0037043704 10.1038/nature00887
169. Brunetti L., Orlando G., Ferrante C., Chiavaroli A., Vacca M., Peptide YY (3-36) inhibits dopamine and norepinephrine release in the hypothalamus. European Journal of Pharmacology 2005 519 1-2 48 51 2-s2.0-27744452561 10.1016/j.ejphar.2005.07.008 (Pubitemid 43181163)
170. Corp E. S., McQuade J., Krasnicki S., Conze D. B., Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats. Peptides 2001 22 3 493 499 2-s2.0-0035091476 10.1016/S0196-9781(01)00359-X (Pubitemid 32250252)
171. Druce M. R., Small C. J., Bloom S. R., Minireview: gut peptides regulating satiety. Endocrinology 2004 145 6 2660 2665 2-s2.0-2542479964 10.1210/en.2004-0089 (Pubitemid 38686212)
172. 3-36 on food intake in humans. Gastroenterology 2005 129 5 1430 1436 2-s2.0-27744584314 10.1053/j.gastro.2005. 09.001 (Pubitemid 41597385)
173. Harding R. K., McDonald T. J., Identification and characterization of the emetic effects of peptide YY. Peptides 1989 10 1 21 24 2-s2.0-0024519128 (Pubitemid 19108029)
174. 3-36 New England Journal of Medicine 2003 349 10 941 948 2-s2.0-0041859261 10.1056/NEJMoa030204 (Pubitemid 37064767)
175. Tong J., D'Alessio D., Eating disorders and gastrointestinal peptides. Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 42 49
176. Ueda S.-Y., Yoshikawa T., Katsura Y., Usui T., Fujimoto S., Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. Journal of Endocrinology 2009 203 3 357 364 2-s2.0-71949084773 10.1677/JOE-09-0190
177. Nguyen A. D., Herzog H., Sainsbury A., Neuropeptide Y and peptide YY: important regulators of energy metabolism. Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 1 56 60 2-s2.0-78650805826 10.1097/MED. 0b013e3283422f0a
178. Labelle M., Boulanger Y., Fournier A., St.-Pierre S., Savard R., Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides 1997 18 6 801 808 2-s2.0-0030865080 10.1016/S0196-9781(97)00028-4 (Pubitemid 27400208)
179. Monteleone P., Castaldo E., Maj M., Neuroendocrine dysregulation of food intake in eating disorders. Regulatory Peptides 2008 149 1-3 39 50 2-s2.0-48849102534 10.1016/j.regpep.2007.10.007
180. Stock S., Leichner P., Wong A. C. K., Ghatei M. A., Kieffer T. J., Bloom S. R., Chanoine J.-P., Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Journal of Clinical Endocrinology and Metabolism 2005 90 4 2161 2168 2-s2.0-17844368601 10.1210/jc.2004-1251 (Pubitemid 40586256)
181. Misra M., Miller K. K., Tsai P., Gallagher K., Lin A., Lee N., Herzog D. B., Klibanski A., Elevated peptide YY levels in adolescent girls with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2006 91 3 1027 1033 2-s2.0-33644824823 10.1210/jc.2005-1878 (Pubitemid 43357776)
182. Nakahara T., Kojima S., Tanaka M., Yasuhara D., Harada T., Sagiyama K.-I., Muranaga T., Nagai N., Nakazato M., Nozoe S.-I., Naruo T., Inui A., Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. Journal of Psychiatric Research 2007 41 10 814 820 2-s2.0-34247846295 10.1016/j.jpsychires. 2006.07.021 (Pubitemid 46693895)
183. Lawson E. A., Eddy K. T., Donoho D., Misra M., Miller K. K., Meenaghan E., Lydecker J., Herzog D., Klibanski A., Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. European Journal of Endocrinology 2011 164 2 253 261 2-s2.0-78751497299 10.1530/EJE-10-0523
184. Germain N., Galusca B., Le Roux C. W., Bossu C., Ghatei M. A., Lang F., Bloom S. R., Estour B., Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. American Journal of Clinical Nutrition 2007 85 4 967 971 2-s2.0-34147153752 (Pubitemid 46557910)
185. Kaye W. H., Berrettini W., Gwirtsman H., George D. T., Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Archives of General Psychiatry 1990 47 6 548 556 2-s2.0-0025311204 (Pubitemid 20189967)
186. Gendall K. A., Kaye W. H., Altemus M., McConaha C. W., La Via M. C., Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biological Psychiatry 1999 46 2 292 299 2-s2.0-0033026175 10.1016/S0006-3223(98)00292-3 (Pubitemid 29320082)
187. Devlin M. J., Kissileff H. R., Zimmerli E. J., Samuels F., Chen B. E., Brown A. J., Geliebter A., Walsh B. T., Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent. Physiology and Behavior 2012 106 2 238 242 2-s2.0-84857465952 10.1016/j.physbeh.2012.02.009
188. Geracioti T. D. Jr., Liddle R. A., Impaired cholecystokinin secretion in bulimia nervosa. New England Journal of Medicine 1988 319 11 683 688 2-s2.0-0023752686
189. Lin H. C., Chey W. Y., Zhao X.-T., Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK. Peptides 2000 21 10 1561 1563 2-s2.0-0033783308 10.1016/S0196-9781(00)00312-0
190. Dockray G. J., Cholecystokinin and gut-brain signalling. Regulatory Peptides 2009 155 1-3 6 10 2-s2.0-67349205060 10.1016/j.regpep.2009.03.015
191. Chandra R., Liddle R. A., Cholecystokinin. Current Opinion in Endocrinology, Diabetes and Obesity 2007 14 1 63 67 2-s2.0-33847706534 10.1097/MED.0b013e3280122850 (Pubitemid 46375391)
192. Gibbs J., Young R. C., Smith G. P., Cholecystokinin decreases food intake in rats. Journal of Comparative and Physiological Psychology 1973 84 3 488 495 2-s2.0-0015701039
193. Degen L., Matzinger D., Drewe J., Beglinger C., The effect of cholecystokinin in controlling appetite and food intake in humans. Peptides 2001 22 8 1265 1269 2-s2.0-0034910191 10.1016/S0196-9781(01)00450-8 (Pubitemid 32703695)
194. Woods S. C., Gastrointestinal Satiety Signals. I. An overview of gastrointestinal signals that influence food intake. American Journal of Physiology. Gastrointestinal and Liver Physiology 2004 286 1 G7 G13 2-s2.0-0347358002 (Pubitemid 38055830)
195. Hisadome K., Reimann F., Gribble F. M., Trapp S., CCK stimulation of GLP-1 neurons involves α 1-adrenoceptor-mediated increase in glutamatergic synaptic inputs. Diabetes 2011 60 11 2701 2709 2-s2.0-80755168940 10.2337/db11-0489
196. Dourish C. T., Rycroft W., Iversen S. D., Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 1989 245 4925 1509 1511 2-s2.0-0024424561 (Pubitemid 19243244)
197. Chen H., Kent S., Morris M. J., Is the CCK2 receptor essential for normal regulation of body weight and adiposity? European Journal of Neuroscience 2006 24 5 1427 1433 2-s2.0-33748744603 10.1111/j.1460-9568.2006.05016.x (Pubitemid 44401665)
198. Clerc P., Constans M. G. C., Lulka H., Broussaud S., Guigné C., Leung-Theung-Long S., Perrin C., Knauf C., Carpéné C., Pénicaud L., Seva C., Burcelin R., Valet P., Fourmy D., Dufresne M., Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology 2007 148 3 1039 1049 2-s2.0-33847045652 10.1210/en.2006-1064
199. Philipp E., Pirke K.-M., Kellner M. B., Krieg J.-C., Disturbed cholecystokinin secretion in patients with eating disorders. Life Sciences 1991 48 25 2443 2450 2-s2.0-0025872668 10.1016/0024-3205(91)90379-P
200. Tamai H., Takemura J., Kobayashi N., Matsubayashi S., Matsukura S., Nakagawa T., Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993 42 5 581 584 2-s2.0-0027217345 10.1016/0026-0495(93)90216-B (Pubitemid 23141628)
201. Harty R. F., Pearson P. H., Solomon T. E., McGuigan J. E., Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regulatory Peptides 1991 36 1 141 150 2-s2.0-0026006298 10.1016/0167-0115(91)90202-R
202. Brambilla F., Brunetta M., Peirone A., T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Research 1995 59 1-2 43 50 2-s2.0-0029616707 10.1016/0165-1781(95) 02664-9 (Pubitemid 26024501)
203. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., Roguski K., Borowiec M., Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes, Obesity and Metabolism 2000 2 2 99 103 2-s2.0-0034520217 10.1046/j.1463-1326.2000.00070.x (Pubitemid 33072164)
204. Cuntz U., Enck P., Frühauf E., Lehnert P., Riepl R. L., Fichter M. M., Otto B., Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa. PLoS ONE 2013 8 e54457
205. Lydiard R. B., Brewerton T. D., Fossey M. D., Laraia M. T., Stuart G., Beinfeld M. C., Ballenger J. C., CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. American Journal of Psychiatry 1993 150 7 1099 1101 2-s2.0-0027195489 (Pubitemid 23198631)
206. Devlin M. J., Walsh B. T., Guss J. L., Kissileff H. R., Liddle R. A., Petkova E., Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. American Journal of Clinical Nutrition 1997 65 1 114 120 2-s2.0-0031016994 (Pubitemid 27020468)
207. Bailer U. F., Kaye W. H., A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Current Drug Targets. CNS and Neurological Disorders 2003 2 1 53 59 2-s2.0-0038132090
208. Hannon-Engel S., Regulating satiety in bulimia nervosa: the role of cholecystokinin. Perspectives in Psychiatric Care 2012 48 1 34 40 2-s2.0-84355163106 10.1111/j.1744-6163.2011.00304.x
209. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425 432 (Pubitemid 24365442)
210. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.-P., Bortoluzzi M.-N., Moizo L., Lehy T., Guerre-Millo M., Marchand-Brustel Y. L., Lewin M. J. M., The stomach is a source of leptin. Nature 1998 394 6695 790 793 2-s2.0-0032552112 10.1038/29547 (Pubitemid 28391644)
211. Jin L., Burguera B. G., Couce M. E., Scheithauer B. W., Lamsan J., Eberhardt N. L., Kulig E., Lloyd R. V., Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. Journal of Clinical Endocrinology and Metabolism 1999 84 8 2903 2911 2-s2.0-0033325799 (Pubitemid 30642029)
212. Frayn K. N., Karpe F., Fielding B. A., Macdonald I. A., Coppack S. W., Integrative physiology of human adipose tissue. International Journal of Obesity 2003 27 8 875 888 2-s2.0-0042166015 10.1038/sj.ijo.0802326 (Pubitemid 36918608)
213. Anubhuti V., Arora S., Leptin and its metabolic interactions-an update. Diabetes, Obesity and Metabolism 2008 10 11 973 993 2-s2.0-54249106761 10.1111/j.1463-1326.2008.00852.x
214. Lammert A., Kiess W., Bottner A., Glasow A., Kratzsch J., Soluble leptin receptor represents the main leptin binding activity in human blood. Biochemical and Biophysical Research Communications 2001 283 4 982 988 2-s2.0-0034805384 10.1006/bbrc.2001.4885 (Pubitemid 32924677)
215. Stein K., Vasquez-Garibay E., Kratzsch J., Romero-Velarde E., Jahreis G., Influence of nutritional recovery on the leptin axis in severely malnourished children. Journal of Clinical Endocrinology and Metabolism 2006 91 3 1021 1026 2-s2.0-33644823425 10.1210/jc.2005-1394 (Pubitemid 43357775)
216. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M., Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 5223 543 546 2-s2.0-0029073613
217. Haynes W. G., Morgan D. A., Walsh S. A., Mark A. L., Sivitz W. I., Receptor-mediated regional sympathetic nerve activation by leptin. Journal of Clinical Investigation 1997 100 2 270 278 2-s2.0-0030876805 (Pubitemid 27349073)
218. Tang-Christensen M., Havel P. J., Jacobs R. R., Larsen P. J., Cameron J. L., Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. Journal of Clinical Endocrinology and Metabolism 1999 84 2 711 717 2-s2.0-0033051923 10.1210/jc.84.2.711 (Pubitemid 29075710)
219. Lissett C. A., Clayton P. E., Shalet S. M., The acute leptin response to GH. Journal of Clinical Endocrinology and Metabolism 2001 86 9 4412 4415 2-s2.0-0034855392 10.1210/jc.86.9.4412 (Pubitemid 32848567)
220. Kalra S. P., Ueno N., Kalra P. S., Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action. Journal of Nutrition 2005 135 5 1331 1335 2-s2.0-18344376775 (Pubitemid 40638359)
221. Carro E., Seoane L. M., Señaris R., Considine R. V., Casanueva F. F., Dieguez C., Interaction between leptin and neuropeptide Y on in vivo growth hormone secretion. Neuroendocrinology 1998 68 3 187 191 2-s2.0-0031718231 10.1159/000054365 (Pubitemid 28427102)
222. Dieguez C., Carro E., Seoane L. M., Garcia M., Camina J. P., Senaris R., Popovic V., Casanueva F. F., Regulation of somatotroph cell function by the adipose tissue. International Journal of Obesity 2000 24 2 S100 S103 2-s2.0-0033941445 10.1038/sj/ijo/0801290 (Pubitemid 30461960)
223. Misra M., Miller K. K., Kuo K., Griffin K., Stewart V., Hunter E., Herzog D. B., Klibanski A., Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. American Journal of Physiology. Endocrinology and Metabolism 2005 289 3 E373 E381 2-s2.0-23944434401 10.1152/ajpendo.00041.2005 (Pubitemid 41192692)
224. Zhao Z., Sakata I., Okubo Y., Koike K., Kangawa K., Sakai T., Gastric leptin, but not estrogen and somatostatin, contributes to the elevation of ghrelin mRNA expression level in fasted rats. Journal of Endocrinology 2008 196 3 529 538 2-s2.0-41149154846 10.1677/JOE-07-0300 (Pubitemid 351425508)
225. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Oikawa S., Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach. Regulatory Peptides 2004 119 1-2 77 81 2-s2.0-1842634405 10.1016/j.regpep.2004.01.012 (Pubitemid 38482105)
226. Tschöp M., Weyer C., Tataranni P. A., Devanarayan V., Ravussin E., Heiman M. L., Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 4 707 709 2-s2.0-0035082265 (Pubitemid 32242624)
227. Frühbeck G., Aguado M., Martinez J. A., In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochemical and Biophysical Research Communications 1997 240 3 590 594 2-s2.0-0031587418 10.1006/bbrc.1997.7716 (Pubitemid 28271762)
228. Frühbeck G., Jebb S. A., Prentice A. M., Leptin: physiology and pathophysiology. Clinical Physiology 1998 18 5 399 419 2-s2.0-0031657939 10.1046/j.1365-2281.1998.00129.x (Pubitemid 28451466)
229. Bai Y., Zhang S., Kim K.-S., Lee J.-K., Kim K.-H., Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. Journal of Biological Chemistry 1996 271 24 13939 13942 2-s2.0-15844410399 10.1074/jbc.271.24.13939 (Pubitemid 26191299)
230. Ahima R. S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. S., Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 6588 250 252 2-s2.0-0029896530 10.1038/382250a0 (Pubitemid 26251358)
231. Holtkamp K., Herpertz-Dahlmann B., Mika C., Heer M., Heussen N., Fichter M., Herpertz S., Senf W., Blum W. F., Schweiger U., Warnke A., Ballauff A., Remschmidt H., Hebebrand J., Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5169 5174 2-s2.0-10744223267 10.1210/jc.2003-030569 (Pubitemid 37452713)
232. Dostalova I., Kopsky V., Duskova J., Papezová H., Pacak K., Nedvidkova J., Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regulatory Peptides 2005 128 63 68 (Pubitemid 40255536)
233. Zepf F. D., Sungurtekin I., Glass F., Elstrodt L., Peetz D., Hintereder G., Kratzsch J., Biskup C. S., Poustka F., Wöckel L., Differences in zinc status and the leptin axis in anorexic and recovered adolescents and young adults: a pilot study. Food and Nutrition Research 2012 56 1 1 8 2-s2.0-84859018960 10.3402/fnr.v56i0.10941
234. Housova J., Anderlova K., Krizová J., Haluzikova D., Kremen J., Kumstyrová T., Papezová H., Haluzik M., Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2005 90 3 1366 1370 2-s2.0-15944402473 10.1210/jc.2004-1364 (Pubitemid 40463989)
235. Monteleone P., Bortolotti F., Fabrazzo M., La Rocca A., Fuschino A., Maj M., Plasma leptin response to acute fasting and refeeding in untreated women with bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2000 85 7 2499 2503 2-s2.0-0034351402 10.1210/jc.85.7.2499 (Pubitemid 32269207)
236. Brewerton T. D., Lesem M. D., Kennedy A., Garvey W. T., Reduced plasma leptin concentrations in bulimia nervosa. Psychoneuroendocrinology 2000 25 7 649 658 2-s2.0-0033859881 10.1016/S0306-4530(00)00016-0 (Pubitemid 30628428)
237. Zipfel S., Specht T., Blum W. F., Hebebrand J., Englaro P., Hartmann M., Wüster C., Ziegler R., Herzog W., Leptin-a parameter for body fat measurement in patients with eating disorders. European Eating Disorders Review 1998 6 38 47 (Pubitemid 28168182)
238. Jimerson D. C., Mantzoros C., Wolfe B. E., Metzger E. D., Decreased serum leptin in bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2000 85 12 4511 4514 2-s2.0-0034485811 10.1210/jc.85.12.4511 (Pubitemid 32157625)
239. Monteleone P., Martiadis V., Colurcio B., Maj M., Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosomatic Medicine 2002 64 6 874 879 2-s2.0-0036858552 10.1097/01.PSY. 0000024239.11538.A5 (Pubitemid 35417130)
240. Vestergaard E. T., Hansen T. K., Nielsen S., Moller N., Christiansen J. S., Jorgensen J. O. L., Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. European Journal of Endocrinology 2005 153 4 545 549 2-s2.0-27644502013 10.1530/eje.1.02000 (Pubitemid 41556282)
241. Inui A., Eating behavior in anorexia nervosa-an excess of both orexigenic and anorexigenic signalling? Molecular Psychiatry 2001 6 6 620 624 2-s2.0-0034747993 10.1038/sj.mp.4000944 (Pubitemid 33020580)
242. Miller K. K., Endocrine dysregulation in anorexia nervosa update. Journal of Clinical Endocrinology and Metabolism 2011 96 10 2939 2949 2-s2.0-80053537863 10.1210/jc.2011-1222
243. Acres M. J., Heath J. J., Morris J. A., Anorexia nervosa, autoimmunity and the hygiene hypothesis. Medical Hypotheses 2012 78 6 772 775 2-s2.0-84860381373 10.1016/j.mehy.2012.03.002
244. Takii M., Uchigata Y., Kishimoto J., Morita C., Hata T., Nozaki T., Kawai K., Iwamoto Y., Sudo N., Kubo C., The relationship between the age of onset of type 1 diabetes and the subsequent development of a severe eating disorder by female patients. Pediatric Diabetes 2011 12 4 396 401 2-s2.0-79957449920 10.1111/j.1399-5448.2010.00708.x
245. Prasad-Reddy L., Disordered eating in type 1 diabetes: insulin omission and diabulimia. U.S. Pharmacist 2012 37 1 8
246. Geiger B. M., Behr G. G., Frank L. E., Caldera-Siu A. D., Beinfeld M. C., Kokkotou E. G., Pothos E. N., Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB Journal 2008 22 8 2740 2746 2-s2.0-48749085707 10.1096/fj.08-110759
247. Van den Eynde F., Treasure J., Neuroimaging in eating disorders and obesity: implications for research. Child and Adolescent Psychiatric Clinics of North America 2009 18 1 95 115 2-s2.0-56149120621 10.1016/j.chc.2008.07.016
248. Batterham R. L., Ffytche D. H., Rosenthal J. M., Zelaya F. O., Barker G. J., Withers D. J., Williams S. C. R., PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007 450 7166 106 109 2-s2.0-35948998870 10.1038/nature06212 (Pubitemid 350070563)
249. Malik S., McGlone F., Bedrossian D., Dagher A., Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metabolism 2008 7 5 400 409 2-s2.0-42649116436 10.1016/j.cmet.2008.03.007 (Pubitemid 351598026)
250. Monteleone P., Serritella C., Martiadis V., Maj M., Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biological Psychiatry 2008 64 11 1005 1008 2-s2.0-55349138111 10.1016/j.biopsych.2008.04.006
251. Kaye W. H., Fudge J. L., Paulus M., New insights into symptoms and neurocircuit function of anorexia nervosa. Nature Reviews Neuroscience 2009 10 8 573 584 2-s2.0-67651097492 10.1038/nrn2682
252. Fladung A.-K., Grön G., Grammer K., Herrnberger B., Schilly E., Grasteit S., Wolf R. C., Walter H., Von Wietersheim J., A neural signature of anorexia nervosa in the ventral striatal reward system. American Journal of Psychiatry 2010 167 2 206 212 2-s2.0-75749151719 10.1176/appi.ajp.2009.09010071
253. Monteleone P., New frontiers in endocrinology of eating disorders. Current Topics in Behavioral Neurosciences 2011 6 189 208
254. Monteleone P., Maj M., Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. Psychoneuroendocrinology 2013 38 312 330
255. Holsen L. M., Lawson E. A., Blum J., Ko E., Makris N., Fazeli P. K., Klibanski A., Goldstein J. M., Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa. Journal of Psychiatry & Neuroscience 2012 37 322 332
256. Capasso A., Petrella C., Milano W., Recent clinical aspects of eating disorders. Reviews on Recent Clinical Trials 2009 4 1 63 69 2-s2.0-62449318197 10.2174/157488709787047594
257. Hebebrand J., Albayrak Ö., Leptin treatment of patients with anorexia nervosa? The urgent need for initiation of clinical studies. European Child and Adolescent Psychiatry 2012 21 2 63 66 2-s2.0-84856185520 10.1007/s00787-012-0243-3
258. Bou Khalil R., de Muylder O., Hebborn F. L., Treatment of anorexia nervosa with TNF- α down-regulating agents. Eating and Weight Disorders 2011 16 e300
259. Bissada H., Tasca G. A., Barber A. M., Bradwejn J., Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry 2008 165 10 1281 1288 2-s2.0-52249097471 10.1176/appi.ajp.2008. 07121900
260. Banks W. A., Blood-brain barrier as a regulatory interface. Forum of Nutrition 2010 63 102 110 2-s2.0-77649215791 10.1159/000264398
261. Hofbauer K. G., Lecourt A.-C., Peter J.-C., Antibodies as pharmacologic tools for studies on the regulation of energy balance. Nutrition 2008 24 9 791 797 2-s2.0-49749107656 10.1016/j.nut.2008.06.001
262. Verhagen L. A. W., Egecioglu E., Luijendijk M. C. M., Hillebrand J. J. G., Adan R. A. H., Dickson S. L., Acute and chronic suppression of the central ghrelin signaling system reveals a role in food anticipatory activity. European Neuropsychopharmacology 2011 21 5 384 392 2-s2.0-79953744366 10.1016/j.euroneuro.2010.06.005
263. Cardona Cano S., Merkestein M., Skibicka K. P., Dickson S. L., Adan R. A. H., Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy. CNS Drugs 2012 26 4 281 296 2-s2.0-84859075535 10.2165/11599890-000000000-00000
264. Herpertz-Dahlmann B., Holtkamp K., Konrad K., Eating disorders: anorexia and bulimia nervosa. Handbook of Clinical Neurology 2012 106 447 462 10.1016/B978-0-444-52002-9.00026-7
265. Hay P. J., Claudino A. M., Clinical psychopharmacology of eating disorders: a research update. International Journal of Neuropsychopharmacology 2012 15 2 209 222 2-s2.0-84857358985 10.1017/S1461145711000460
266. Kishi T., Kafantaris V., Sunday S., Sheridan E. M., Correll C. U., Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. Journal of Clinical Psychiatry 2012 73 e757 e766
267. Garcia F. D., Coquerel Q., do Rego J.-C., Cravezic A., Bole-Feysot C., Kiive E., Déchelotte P., Harro J., Fetissov S. O., Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder. Psychoneuroendocrinology 2012 73 9 1457 1467 2-s2.0-84857217106 10.1016/j.psyneuen.2012.01.015
268. Fetissov S. O., Déchelotte P., The new link between gut-brain axis and neuropsychiatric disorders. Current Opinion in Clinical Nutrition and Metabolic Care 2011 14 5 477 482 2-s2.0-80051780284 10.1097/MCO.0b013e32834936e7